Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome
Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome
The purpose of this study is to determine the efficacy of blood restriction therapy by
 comparing increase in muscle mass and strength in patients that receive blood restriction
 therapy to patients who receive a placebo.
Inclusion Criteria:

 -  ASA class I-II

 -  Diagnosed with patellofemoral pain syndrome

 Exclusion Criteria:

 -  Patients with confirmed radiographic evidence explaining knee pain

 -  Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia,
 etc.)

 -  Younger than 18 years of age or older than 65

 -  Any patient considered a vulnerable subject

 -  Patients with impaired circulation, peripheral vascular compromise, Previous
 revascularization of the extremity, or severe hypertension

 -  Patients with Sickle cell anemia or venous thromboembolism

 -  Patients with Sickle cell anemia or venous thromboembolism

 -  Patients with cancer or Lymphectomies

 -  Patients with increased intracranial pressure